|
1
|
McDowell HP: Update on childhood
rhabdomyosarcoma. Arch Dis Child. 88:354–357. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hicks J and Flaitz C: Rhabdomyosarcoma of
the head and neck in children. Oral Oncol. 38:450–459. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Walterhouse D and Watson A: Optimal
management strategies for rhabdomyosarcoma in children. Paediatr
Drugs. 9:391–400. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Herrmann BW, Sotelo-Avila C and Eisenbeis
JF: Pediatric sinonasal rhabdomyosarcoma: Three cases and a review
of the literature. Am J Otolaryngol. 24:174–180. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lawrence W Jr, Anderson JR, Gehan EA and
Maurer H: Pretreatment TNM staging of childhood rhabdomyosarcoma: A
report of the Intergroup Rhabdomyosarcoma Study Group. Children's
Cancer Study Group. Pediatric Oncology Group. Cancer. 80:1165–1170.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fyrmpas G, Wurm J, Athanassiadou F,
Papageorgiou T, Beck JD, Iro H and Constantinidis J: Management of
paediatric sinonasal rhabdomyosarcoma. J Laryngol Otol.
123:990–996. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pappo AS, Shapiro DN, Crist WM and Maurer
HM: Biology and therapy of pediatric rhabdomyosarcoma. J Clin
Oncol. 13:2123–2139. 1995.PubMed/NCBI
|
|
8
|
Ahmed AA and Tsokos M: Sinonasal
rhabdomyosarcoma in children and young adults. Int J Surg Pathol.
15:160–165. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumar S, Perlman E, Harris CA, Raffeld M
and Tsokos M: Myogenin is a specific marker for rhabdomyosarcoma:
An immunohistochemical study in paraffin-embedded tissues. Mod
Pathol. 13:988–993. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cessna MH, Zhou H, Perkins SL, Tripp SR,
Layfield L, Daines C and Coffin CM: Are myogenin and MyoD1
expression specific for rhabdomyosarcoma? A study of 150 cases,
with emphasis on spindle cell mimics. Am J Surg Pathol.
25:1150–1157. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Meza JL, Anderson J, Pappo AS and Meyer
WH: Children's Oncology Group: Analysis of prognostic factors in
patients with nonmetastatic rhabdomyosarcoma treated on intergroup
rhabdomyosarcoma studies III and IV: The Children's Oncology Group.
J Clin Oncol. 24:3844–3851. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sturgis EM and Potter BO: Sarcomas of the
head and neck region. Curr Opin Oncol. 15:239–252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Daya H, Chan HS, Sirkin W and Forte V:
Pediatric rhabdomyosarcoma of the head and neck: Is there a place
for surgical management? Arch Otolaryngol Head Neck Surg.
126:468–472. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gosiengfiao Y, Reichek J and Walterhouse
D: What is new in rhabdomyosarcoma management in children? Paediatr
Drugs. 14:389–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Buwalda J, Blank LE, Schouwenburg PF,
Copper MP, Strackee SD, Voûte PA, Merks JH and Caron HN: The AMORE
protocol as salvage treatment for non-orbital head and neck
rhabdomyosarcoma in children. Eur J Surg Oncol. 30:884–892. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Paulino AC, Bauman N, Simon JH, Nguyen TX,
Ritchie JM and Tannous R: Local control of parameningeal
rhabdomyosarcoma: Outcomes in non-complete responders to
chemoradiation. Med Pediatr Oncol. 41:118–122. 2003. View Article : Google Scholar : PubMed/NCBI
|
